Lupin Gets US FDA Nod for Generic Triumeq PD Tablets to Treat HIV-1

Global pharma major Lupin Limited (Lupin) announced that it has received tentative approval from the United States Food and Drug Administration (FDA) under the US President’s Emergency Plan for AIDS Relief (PEPFAR) for its Abbreviated New Drug Application for abacavir, dolutegravir and lamivudine tablets for oral suspension, 60 mg/5 mg/30 mg, to market a generic equivalent of Triumeq PD tablets for oral suspension, of ViiV Healthcare Company.
 
This product would be manufactured at Lupin’s Nagpur facility in India and will be supplied to low-and middle-income countries.
 
The fixed-dose combination of abacavir 60 mg/dolutegravir 5 mg/lamivudine 30 mg tablets for oral suspension is a once-daily single-pill regimen, indicated for the treatment of HIV-1 infection in paediatric patients aged at least 3 months and weighing at least 6 kg.
 
Ramesh Swaminathan, executive director, global CFO & head of API Plus SBU, Lupin stated, “We are committed to providing affordable and high-quality treatments for patients worldwide. The tentative approval from the US FDA for our abacavir, dolutegravir and lamivudine tablets enables us to improve the well-being of paediatric patients with HIV-1, thereby significantly boosting our HIV medication portfolio.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!